Seroepidemiology and Risk Factors Of Blood-Borne Virus Infections Among Drug Users in Uppsala County, Sweden
Staffan P.E. Sylvan*, 1, Johan Hedlund1, Gunilla Ohlén1, Eva Lundell2, Kare Bondeson3, the Uppsala County Working Group Against Drug Dependency
Identifiers and Pagination:Year: 2008
First Page: 27
Last Page: 31
Publisher Id: TOIDJ-2-27
Article History:Received Date: 01/08/2008
Revision Received Date: 29/08/2008
Acceptance Date: 02/09/2008
Electronic publication date: 7/10/2008
Collection year: 2008
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The prevalence, risk factors, and prevention opportunities of hepatitis A, B, C and HIV infection was studied in injecting drug users (IDUs) in comparison with non-injecting drug users (n-IDUs) in Uppsala County, Sweden.
The seroprevalence among IDUs were 0.7% for HIV, 19% for HAV, 26% for HBV and 63% for HCV. For hepatitis C, the seroprevalence was directly related to the number of years of injections. No cases of HIV were found among the n- IDUs and the seroprevalence rate was significantly lower for HBV and HCV, 6 and 2%, respectively. In contrast, the anti- HAV antibody seroprevalence was not significantly different between n-IDUs and IDUs (27% vs 19%, p< ns). There was no difference in vaccination uptake among IDUs compared with n-IDUs.
Hepatitis A and B vaccination should be considered as one component of a comprehensive programme including counselling, support and education of blood-borne infections associated with drug use.